{"id":75151,"date":"2026-10-29T03:00:29","date_gmt":"2026-10-29T00:00:29","guid":{"rendered":"https:\/\/www.pharmamanage.gr\/how-do-pharmacies-benchmark-performance\/"},"modified":"2026-10-29T03:00:29","modified_gmt":"2026-10-29T00:00:29","slug":"how-do-pharmacies-benchmark-performance","status":"publish","type":"post","link":"https:\/\/www.pharmamanage.gr\/en\/how-do-pharmacies-benchmark-performance\/","title":{"rendered":"How Do Pharmacies Benchmark Their Performance?"},"content":{"rendered":"

A pharmacy can report higher sales than last year and still be losing ground. A new competitor, a shift in prescription mix, higher labor costs, or a weak front-end category can all be concealed by topline growth. That is why the question is not simply whether results improved, but how do pharmacies benchmark performance against a relevant standard and use the findings to make better decisions?<\/p>\n

Benchmarking is the disciplined comparison of a pharmacy’s results with its own prior performance, a defined peer group, or a target that reflects its strategic goals. Done well, it replaces instinct with evidence. Done poorly, it creates misleading comparisons between pharmacies that serve very different populations, operate under different reimbursement conditions, or carry different service responsibilities.<\/p>\n

How Do Pharmacies Benchmark Performance Effectively?<\/h2>\n

The starting point is to define what the pharmacy is trying to improve. A store focused on prescription volume, adherence services, and payer relationships should not use the same scorecard as a pharmacy building a differentiated wellness, beauty, or home-health business. Both need financial discipline, but their measures of success will differ.<\/p>\n

A useful benchmarking program typically combines three reference points. Internal benchmarking compares current performance with the pharmacy’s own history. Peer benchmarking compares results with pharmacies of similar size, format, location, and prescription mix. Strategic benchmarking measures progress against a deliberate target, such as reducing wait times, expanding vaccination capacity, or increasing margin in a priority category.<\/p>\n

These comparisons should answer a management question. If front-end sales are below peer levels, for example, the next question is whether the problem lies in traffic, conversion, assortment, pricing, display execution, or staff confidence in recommending appropriate products. The benchmark identifies where to investigate. It does not supply the diagnosis by itself.<\/p>\n

Build a Comparable Peer Group Before Comparing Results<\/h2>\n

The most common benchmarking error is comparing unlike businesses. An urban pharmacy with extended hours, high prescription volume, and limited retail space should not be judged against a suburban destination store with ample parking and a large wellness assortment. The result may be an unrealistic target and the wrong operational response.<\/p>\n

A credible peer group should account for factors that materially affect performance: prescription volume, store format, geographic setting, operating hours, payer and reimbursement mix, staffing model, retail footprint, and the services offered. A pharmacy with a large long-term care or delivery operation also needs to separate those activities from walk-in retail performance where possible.<\/p>\n

Location deserves particular attention. Demographics, local competition, nearby medical practices, transportation access, and community health needs influence both demand and product mix. A pharmacy serving an older population may reasonably see stronger results in mobility, continence, and medication services than in prestige beauty. That is not underperformance. It is a different commercial model.<\/p>\n

Peer data may come from buying groups, wholesalers, pharmacy associations, financial advisors, point-of-sale providers, or a multi-store operator’s internal network. Whatever the source, managers should understand the definitions behind the figures. \u201cSales,\u201d \u201cmargin,\u201d and \u201ctransactions\u201d can be calculated differently across systems. Comparing inconsistent definitions creates false precision.<\/p>\n

Measure the Metrics That Explain Performance<\/h2>\n

A broad scorecard is useful, but it should not become an administrative burden. Pharmacy owners and managers need a limited set of measures that connect directly to patient experience, operational control, and financial outcomes.<\/p>\n

Prescription Operations<\/h3>\n

Prescription volume remains a central indicator, but volume alone is not enough. Track prescriptions dispensed per labor hour, average time from intake to ready status, refill capture rate, abandonment or return-to-stock rate, and inventory turns. These metrics show whether growth is being handled efficiently or merely creating additional pressure on the team.<\/p>\n

Labor productivity requires context. A lower prescriptions-per-labor-hour figure may be justified when pharmacists provide extensive clinical services, manage complex medication synchronization programs, or serve a high proportion of patients needing consultation. The goal is not to maximize speed at the expense of care. It is to identify whether staffing and workflow match the pharmacy’s service model.<\/p>\n

Financial Health<\/h3>\n

Benchmark gross profit dollars and gross margin percentage separately. Higher sales can produce disappointing profit if reimbursement pressure, discounting, shrink, or a low-margin mix is eroding contribution. Monitor revenue and margin by prescription, over-the-counter, wellness, beauty, durable medical equipment, and other relevant departments.<\/p>\n

Operating expense ratios matter just as much. Payroll, occupancy, delivery, technology, and inventory carrying costs should be reviewed against sales and against gross profit. A pharmacy may appear efficient on a sales basis while labor costs are becoming unsustainable relative to the gross profit available to support them.<\/p>\n

Front-End and Category Performance<\/h3>\n

For non-prescription categories, compare sales per square foot, gross margin, inventory turns, units per transaction, and sell-through by category. This reveals whether a category is genuinely productive or merely occupying valuable space.<\/p>\n

Category benchmarks should guide merchandising decisions, not dictate them blindly. A low-selling seasonal health category may still deserve a focused display if it meets a local patient need and supports the pharmacy’s professional positioning. Conversely, a category with high sales but weak margin or excessive markdowns may need tighter assortment management.<\/p>\n

Patient Experience and Service Delivery<\/h3>\n

The strongest pharmacies do not treat experience metrics as soft measures. Waiting time, complaint themes, refill reminders completed, vaccination appointments kept, service uptake, and patient retention all affect financial performance over time.<\/p>\n

Patient feedback should be read alongside operational data. If wait times are improving<\/a> but satisfaction is falling, the pharmacy may have introduced a process that feels impersonal or confusing. If satisfaction is high but workflow is slow, the team may be delivering excellent service at an avoidable cost. Both situations require a balanced response.<\/p>\n

Normalize Data Before Drawing Conclusions<\/h2>\n

Raw figures can be deceptive. A pharmacy that dispenses 3,000 prescriptions a week will naturally have more errors, calls, and returns in absolute numbers than a pharmacy dispensing 1,000. Ratios make results comparable.<\/p>\n

Use measures such as margin per prescription, labor hours per 100 prescriptions, sales per square foot, inventory days on hand, and service revenue per eligible patient. When reviewing trends, adjust for seasonal events, unusual supply disruptions, holidays, local closures, and major payer changes. A single month rarely tells the whole story.<\/p>\n

Managers should also separate controllable from less controllable drivers. A reimbursement reduction may affect margin across the business, but purchasing discipline, generic substitution processes, inventory levels, and the mix of service offerings remain management levers. Benchmarking becomes useful when it directs attention to actions the pharmacy can take.<\/p>\n

Turn the Scorecard Into a Management Routine<\/h2>\n

Benchmarking has limited value if it is reviewed once a year in a spreadsheet. The best approach is a regular management rhythm: weekly monitoring for operational exceptions, monthly review of department and financial trends, and quarterly evaluation of strategic priorities.<\/p>\n

A practical monthly scorecard may include five areas:<\/p>\n